» Articles » PMID: 26571462

Key Role of Pancreatic Stellate Cells in Pancreatic Cancer

Overview
Journal Cancer Lett
Specialty Oncology
Date 2015 Nov 17
PMID 26571462
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic stellate cells (PSCs) are responsible for producing the collagenous stroma in pancreatic cancer. Findings from the majority of in vitro and in vivo studies to date indicate that PSCs interact with cancer cells as well as with other cellular elements in the stroma including immune cells, endothelial cells and neuronal cells to set up a growth permissive microenvironment for pancreatic tumours. However, two recent studies reporting a protective effect of myofibroblasts in pancreatic cancer have served to remind researchers of the possibility that the role of PSCs in this disease may be context and time-dependent, such that any possible early protective role of PSCs is subverted in later stages by the ability of cancer cells to turn PSCs into cancer-promoting aides. This concept is supported by the development in recent years of several novel therapeutic approaches targeting the stroma that have been successfully applied in pre-clinical settings to inhibit disease progression. A multi-pronged approach aimed at tumour cells as well as stromal elements may be the key to achieving better clinical outcomes in patients with pancreatic cancer.

Citing Articles

Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method.

Feng Q, Shan X, Yau V, Cai Z, Xie S Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861125 PMC: 11769033. DOI: 10.3390/ph18010062.


Genetics and biology of pancreatic ductal adenocarcinoma.

Ying H, Kimmelman A, Bardeesy N, Kalluri R, Maitra A, DePinho R Genes Dev. 2024; 39(1-2):36-63.

PMID: 39510840 PMC: 11789498. DOI: 10.1101/gad.351863.124.


MSLN induced EMT, cancer stem cell traits and chemotherapy resistance of pancreatic cancer cells.

Hu J, Wang J, Guo X, Fan Q, Li X, Li K Heliyon. 2024; 10(8):e29210.

PMID: 38628720 PMC: 11019237. DOI: 10.1016/j.heliyon.2024.e29210.


Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer.

Uehara M, Domoto T, Takenaka S, Takeuchi O, Shimasaki T, Miyashita T Cancer Drug Resist. 2024; 7:4.

PMID: 38318525 PMC: 10838383. DOI: 10.20517/cdr.2023.84.


The diverse influences of relaxin-like peptide family on tumor progression: Potential opportunities and emerging challenges.

Jung J, Han H Heliyon. 2024; 10(2):e24463.

PMID: 38298643 PMC: 10828710. DOI: 10.1016/j.heliyon.2024.e24463.